 | Monter d'un niveau |
Alameh, M., DeJesus, D., Benhamadi, M., Jean, M., Buschmann, M. D., & Merzouki, A. (mai 2011). Chitosan nanoparticulate system for the delivery of siRNA targeting genome caretakers for the development of potential cancer therapies [Communication écrite]. 1st Meeting of Canadian Chapter of The Controlled Release Society, Montréal, Québec. Non disponible
DeJesus, D., Alameh, M., Jean, M., Lascau, V., Buschmann, M. D., & Merzouki, A. (mai 2011). Therapeutic lowering of circulating ApoB in atherosclerotic mice by intravenous administration of chitosan-siRNA nanoparticles [Communication écrite]. 1st Meeting of Canadian Chapter of The Controlled Release Society, Montréal, Québec. Non disponible
Jean, M., Alameh, M., Daras, V., Lavertu, M., Thibault, M., Buschmann, M. D., & Merzouki, A. (mai 2011). Effective and safe gene-based delivery of GLP-1 using chitosan/plasmid-DNA therapeutic nanocomplexes in an animal model of Type 2 Diabetes [Communication écrite]. 14th Annual Meeting American Society of Gene and Cell Therapy, Seattle, WA, USA. Non disponible
Jean, M., Alameh, M., Daras, V., Lavertu, M., Thibault, M., Buschmann, M. D., & Merzouki, A. (mai 2011). Effective and safe gene-based delivery of GLP-1 using chitosan/plasmid-DNA therapeutic nanocomplexes in an animal model of Type 2 Diabetes [Communication écrite]. 1st Meeting of Canadian Chapter of The Controlled Release Society, Montréal, Québec, Canada. Non disponible
